Stop parsing PDFs. Get the API. Request Access

AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

El.En.

Investor Presentation • Dec 4, 2018

4393_cp_2018-12-04_0f3e4654-213e-4c1c-b3f2-965acc304dd2.pdf

Investor Presentation

Open in Viewer

Opens in native device viewer

Intermonte – December 2018

DISCLAIMER

Certain statements in this slide show, including those addressing the Company's beliefs, plans, objectives, estimates or expectations of possible future results or events, are forward-looking statements. Forward-lookingstatements involve known or unknown risks, including general economic and business conditions, and conditions in the industry we operate and may be affected should our assumptions turn out to be inaccurate. Consequently, no forward-looking statement can be guaranteed and actual future results, performance, or achievements may vary materially from those expressed or implied by such forward-looking statements. The Company undertakes no obligation about the contents nor to update the forward-looking statements to reflect events or circumstances that may arise after the date hereof.

AGENDA

El.En.

A Primary Player Providing Medical, Industrial, and Conservation Laser Solutions Worldwide

Hi-Tech company

Hi-Tech industrial group active in opto-electronics with proprietary technologies and know how developed over 35 years

International Group

More than 20 companies active worldwide on several markets and application segments. Listed on the Milan Stock Exchange, Star segment since 2000

Among the leaders in the global market

Progressively widening its worldwide presence registering continuous growth over the years

Worldwide distribution network

1,400 employees worldwide; 38 years average age

More than 40,000 laser sources sold and 5% of revenue invested in R&D

Constant and sustainable growth

14% Revenue CAGR 2011 – 2017

35% EBIT CAGR 2011 – 2017

FY 2017 Consolidated Revenue: €306m, up 21% YoY

A PATH OF GROWTH

in Euro million

Our Markets

Medical& Aesth energy-based systems market

\$
l
l
i
i
U
S
m
o
n		 2
0
1
4		 2
0
1
6		 2
0
2
1		 C
A
G
R		 C
A
G
R
1
4-
1
6		 1
6-
2
1
l
b
l
d
l
l
G
i
i
i
i
o
a
n
o
n-
n
v
a
s
v
e
a
n
m
n
m
a
y
d
l
h
i
i
i
i
t
t
t
t
t
n
v
a
s
v
e
m
e
c
a
a
e
s
e
c
r
e
a
m
e
n
t
s
y
s
e
m
s		 6.
9
3
2		 8.
4
3
7		 1
3.
9
9
2		 1
0
%		 1
1
%
b
d
E
t
t
t
t
n
e
r
g
y
a
s
e
r
e
a
m
e
n
s
y
s
e
m
s
-		 2.
0
3
3		 2.
6
7
0		 4.
3
8
0		 1
5
%		 1
0
%
d
h
k
h
B
i
&
S
i
i
i
t
t
o
y
s
a
p
n
g
n
g
e
n
n
g		 7
2
4		 9
9
6		 1.
9
6
5		 1
7
%		 1
5
%
k
S
i
j
i
t
n
r
e
u
v
e
n
a
o
n		 2
3
5		 6
9
5		 1.
0
8
9		 1
%
5		 9
%
l
i
H
a
r
r
e
m
o
v
a		 3
3
5		 3
4
1		 3
3
3		 -2
%		 0
%
i
L
t
t
t
e
g
e
n
r
e
a
m
e
n
s
v		 3
1
1		 1
5
7		 8
1
7		 9
%		 %
4
d
A
i
t
c
n
e
r
e
u
c
o
n		 9
6		 1
1
0		 1
2
5		 7
%		 3
%
l
V
i
j
i
t
a
g
n
a
r
e
u
v
e
n
a
o
n		 n
a		 1
0
5		 3
3
2		 n
a		 2
6
%
d
l
&
l
P
i
i
t
t
t
t
g
m
e
n
e
e
s
o
n
a
o
o
r
e
m
o
v
a		 8
0		 9
9		 1
4
2		 1
1
%		 7
%
h
O
t
e
r		 1
2
6		 1
6
7		 2
0
7		 1
5
%		 4
%
l
T
t
o
a		 2.
0
3
3		 2.
6
0
7		 4.
3
8
0		 1
%
5		 1
0
%

Source: Medical Insight Report

Key growth drivers:

  • Increasingly aging population
  • Desire to achieve or maintain more youthful appearance
  • Increase in healthcare spending
  • Requirements for fast and minimally invasive surgical procedures

Industrial laser market

Lasers increasingly adopted in high quality manufacturing for uniqueness, flexibility, environment friendliness, productivity

  • •Sheet metal cutting: technology breakthroughs lead to strong widening of demand
  • •Laser marking for identification: traceability as a quality standard

MARKET STUDIES:

Technavio's analysts forecast :"The global industrial laser market to grow at a CAGR of 10.24% during the period 2017-2021"

Growth drivers

Growthdrivers

  • Expected growth in our main markets: Aesthetic , Surgery, Industrial
  • Entering the body contouring and cellulite treatment market
  • Novel dermatologic treatment device: 2019
  • Diabetic foot ulcers: seeking regulatory clearances worldwide
  • New manufacturing applications for medium power CO2 laser sources
  • Strong demand for high power laser sheet metal cutting systems in China and Europe
  • New laser systems for hair removal

New systemsand devices

  • ONDA Body contouring
  • Motus AX expands to Motus AY
  • BPH: Virtual basket and single use morcellator
  • High Power sheet metal cutting systems 20kW
  • OEM systems for urology 100 W Ho:YAG
  • New accessories for CO2surgery
  • MIS MLS High Peak Pulse for physiotherapy

New factories

Jena

Financial Highlights

IncomeStatement 9M-2018

3
0
0
9
1
7		 % 3
0
0
9
1
8		 % V
%
a
r.
d
d
i
t
u
n
a
u
e		 d
d
i
t
u
n
a
u
e
1
2
4
0
0
7		 5
6
8
%
,		 1
3
8
8
3
7		 5
7
0
%
,		 1
2
0
%
,
9
4
4
0
5		 %
4
3
2
,		 1
0
4
6
0
0		 %
4
3
0
,		 %
1
0
8
,
2
1
8
4
1
2		 1
0
0
0
%		 2
4
3
4
3
7		 1
0
0
0
%		 1
1,
5
%
9
0
8
9
9		 4
1,
6
%		 9
6
3
0
6		 3
9
6
%
,		 5
9
%
,
2
6
5
4
8		 1
2
2
%
,		 2
4
0
3
6		 9
9
%
,		 9
5
%
-
,
2
2
1
6
0		 1
0
1
%
,		 2
0
0
0
7		 8
2
%
,		 9
7
%
-
,
1
9
1
0
8		 %
8
7
,		 1
9
9
0
8		 %
8
2
,		 %
4
2
,
d
d
i
t
u
n
a
u
e
8
4
0
6
5		 4
8
1
0
5
/
/
/
/
3
1
1
2
1
7		 , /
/
/
/
3
0
0
9
1
8		 ,

Cash Flow 9M-2018

Revenue breakdown by area 9M-2018

Revenue breakdown 9M-2018

Guidance

Multiples & Comparables

Multiples

's
k
h
l
d
i
h
S
E
t
t
o
c
o
e
r
q
p
e
r
s
a
r
e
u
y		 9,
9
/
i
k
l
d
j.
P
B
V
A
r
c
e
o
o
a
u
e		 1,
5
/
(
)
8
0
%
E
V
E
B
I
T
E
B
I
T		 0,
0
1
/
(
)
l
l
E
V
S
8
0
%
S
a
e
s
a
e
s		 0,
8
l.
k
E
E
M
C
t
n.
a
r
e
a
p.		 @
2
7
9,
8		 €
1
4,
5
0
f
i
i
l
i
i
N
t
t
e
n
a
n
c
a
p
o
s
o
n		 @
5
4,
8		 /
/
3
0
0
9
1
8
/
l
l
i
i
i
F
t
t
t
n
a
n
c
a
n
v
e
s
m
e
n
s
m
e
r
m		 2,
2
@
1		 /
/
3
0
0
9
8
1
l
i
E
V
t
n
e
r
p
r
s
e
a
u
e		 2
1
2,
8

Comparables

Am
nts
ou		 in m
ln
h,
Se
3
0
2
0
1
8
t.
t
p
Pr
ice		 Re
ve
nu
e		 Va
%
r.		 E
B
I
T		 E
B
I
T
%		 M
K.
Ca
p.		 E
V		 /
les
E
V
Sa		 /
E
V
E
B
I
T		 /
k
P
Bo
o
/
d
l
he
M
ica
Ae
ic
t
t
e
s		 Re
v.		 (
*)		 (
*)		 lu
Va
e
Cu
te
ra		 \$
2
0,
7
7		 \$
1
1
7		 1
3
%		 \$
(
)
8		 %
-7		 \$
2
8
9		 \$
2
6
2		 1,
7		 n.
a.		 1
4,
(
)
S
isr
d
ica
l
2
M
am
e		 \$
0,
6
2		 \$
8
7		 8
%
1		 \$
1
4		 8
%
1		 \$
2
7
7		 \$
8
3
1		 2
1,		 6,
5		 0,
9
ic
Lu
tro
n		 €
7,
2
2		 €
4
9		 -3
%		 -€
8		 -1
6
%		 €
1
7
9		 €
1
6
5		 2,
6		 n.
a.		 1,
7
du
ia
l
tr
s
ho
ics
P
G
P
Co
to
n		 \$
1
4
1,
8
3		 \$
1.
1
3
0		 8
%		 \$
4
2
7		 3
8
%		 \$
7.
5
2
0		 \$
6.
4
0
2		 4,
2		 1
1,
2		 3,
4
In
I
im
du
ie
Pr
In
tr
a
s		 €
2
0,
6
5		 €
3
1
8		 6
%		 €
1
7		 5
%		 €
2
1
6		 €
3
1
5		 0,
7		 1
3,
6		 1,
4
's
Ha
La
n
se
r		 ¥
3
2,
1
4		 ¥
8.
6
5
6		 -3
%		 ¥
1.
5
9
0		 1
8
%		 ¥
3
4.
3
0
0		 ¥
3
4.
3
3
9		 3,
0		 1
6,
2		 3,
8

Contacts

El.En. SPA

Enrico ROMAGNOLI Investor Relations Managertel. +39 055-8826807E-mail: [email protected]

POLYTEMS HIR

Financial Communication, IR and Press Office Bianca FERSINI MASTELLONI [email protected] MARONGIU [email protected]. +39 06-69923324

More from El.En.

Regulatory Filings 2025
Dec 22
Transaction in Own Shares 2025
Dec 22
Share Issue/Capital Change 2025
Dec 22
Transaction in Own Shares 2025
Dec 3
Investor Presentation 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Report Publication Announcement 2025
Dec 3
Registration Form 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
Share Issue/Capital Change 2025
Nov 28
View all filings →

Talk to a Data Expert

Have a question? We'll get back to you promptly.